retatrutide and menopause Vs. Tirzepatide: Key Differences Explained MENOPAUSAL WEIGHT GAIN AND GLP1

US Judge Denies Injunction, Restricting Copies of Lilly Weight-Loss Drug. Reuters

Dysbiosis, or an imbalance in gut microbiota, is associated with metabolic diseases, especially T2DM, and can cause changes in the signaling pathways of intestinal hormone secretion, leading to various health problems [156]

Hypoglycemia risk : Lower risk than with insulin, but non-trivial if combined with other glucose-lowering medications

Gearhardt and DiFeliceantonio, 2023

The presence of thyroid peroxidase (TPO) antibodies or thyroglobulin antibodies supports an autoimmune aetiology but is not essential for diagnosis

Now that name-brand medications are more widely available, the need for compounded versions is significantly reduced